Sanofi Genzyme Announces Recipients of 2016 Patient Advocacy Leadership (PAL) Awards

Sanofi Genzyme Announces Recipients of 2016 Patient Advocacy Leadership (PAL) Awards

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sanofi Genzyme, the specialty care global business unit of Sanofi, today announced the recipients of the sixth annual Patient Advocacy Leadership (PAL) Awards. The global PAL Awards program supports projects by non-profit organizations that serve patients living with lysosomal storage disorders (LSDs), a group of rare, inherited disorders that can cause progressive and debilitating health problems.

Sanofi Genzyme Announces Recipients of Patient Advocacy Leadership (PAL) Awards

Sanofi Genzyme Announces Recipients of Patient Advocacy Leadership (PAL) Awards

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sanofi Genzyme, the specialty care global business unit of Sanofi, today announced the recipients of the fifth annual Patient Advocacy Leadership (PAL) awards. The global grant program supports projects by non-profit organizations that serve patients living with lysosomal storage disorders (LSDs), a group of rare, inherited disorders that can cause progressive and debilitating health problems.